Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Genz-682452
2. Gz-sar402671
3. Ibiglustat
1. Ibiglustat
2. 1401090-53-6
3. Genz-682452
4. Sar402671
5. Gz/sar402671
6. Genz-682452-aa
7. Venglustat [usan]
8. Gz402671
9. Blp1xa3fza
10. (s)-quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate
11. Sar-402671
12. [(3s)-1-azabicyclo[2.2.2]octan-3-yl] N-[2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl]carbamate
13. Gz-402671
14. (3s)-1-azabicyclo(2.2.2)octan-3-yl N-(2-(2-(4-fluorophenyl)-1,3-thiazol-4-yl)propan-2-yl)carbamate
15. Carbamic Acid, N-(1-(2-(4-fluorophenyl)-4-thiazolyl)-1-methylethyl)-, (3s)-1-azabicyclo(2.2.2)oct-3-yl Ester
16. Carbamic Acid, N-[1-[2-(4-fluorophenyl)-4-thiazolyl]-1-methylethyl]-, (3s)-1-azabicyclo[2.2.2]oct-3-yl Ester
17. Ibiglustat [inn]
18. Unii-blp1xa3fza
19. Venglustat [inn]
20. Venglustat (usan/inn)
21. Ibiglustat(genz-682452
22. Venglustat [who-dd]
23. Chembl4297611
24. Schembl12615329
25. Gtpl11550
26. Gz/sar-402671
27. Amy19519
28. Bgc09053
29. Ex-a1870
30. Mfcd28502073
31. Who 10063
32. Akos027337125
33. Zinc202143443
34. Cs-6512
35. Db14966
36. Ac-35551
37. As-52367
38. Hy-16743
39. D11633
40. P14969
41. Q27274745
42. (s)-quinuclidin-3-yl 2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-ylcarbamate
43. (s)-quinuclidin-3-yl(2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate
| Molecular Weight | 389.5 g/mol |
|---|---|
| Molecular Formula | C20H24FN3O2S |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 389.15732635 g/mol |
| Monoisotopic Mass | 389.15732635 g/mol |
| Topological Polar Surface Area | 82.7 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 533 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of polycystic kidney disease
Treatment of Parkinson's disease
Treatment of autosomal dominant polycystic kidney disease
Treatment of galactosialidosis, Treatment of GM1 gangliosidosis, Treatment of GM2 gangliosidosis, Treatment of sialidosis
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
19
PharmaCompass offers a list of Venglustat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Venglustat manufacturer or Venglustat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Venglustat manufacturer or Venglustat supplier.
PharmaCompass also assists you with knowing the Venglustat API Price utilized in the formulation of products. Venglustat API Price is not always fixed or binding as the Venglustat Price is obtained through a variety of data sources. The Venglustat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Venglustat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Venglustat, including repackagers and relabelers. The FDA regulates Venglustat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Venglustat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Venglustat supplier is an individual or a company that provides Venglustat active pharmaceutical ingredient (API) or Venglustat finished formulations upon request. The Venglustat suppliers may include Venglustat API manufacturers, exporters, distributors and traders.
Venglustat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Venglustat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Venglustat GMP manufacturer or Venglustat GMP API supplier for your needs.
A Venglustat CoA (Certificate of Analysis) is a formal document that attests to Venglustat's compliance with Venglustat specifications and serves as a tool for batch-level quality control.
Venglustat CoA mostly includes findings from lab analyses of a specific batch. For each Venglustat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Venglustat may be tested according to a variety of international standards, such as European Pharmacopoeia (Venglustat EP), Venglustat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Venglustat USP).
